New study tracks hidden heart risks in breast cancer therapy
Knowledge-focused
Not yet recruiting
This observational study follows 100 women with early-stage breast cancer who are receiving standard chemotherapy or anti-HER2 therapy. Researchers want to see if certain heart tests and blood markers can detect early signs of heart damage before it becomes serious. Participants …
Sponsor: Fatih GURLER • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC